Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive study reveals hidden dangers of common steroid treatments

NCT ID NCT06488703

Completed Knowledge-focused Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking risks such as diabetes, heart disease, osteoporosis, and infections. The goal was to measure how often these side effects occur and their economic impact on the healthcare system.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
systemic glucocorticoids (steroids)
What this could lead to
If successful, this research could help doctors better weigh the risks of long-term steroid use and find ways to reduce harmful side effects.
What could go wrong
This is a retrospective analysis of existing data, not a controlled trial. It can show links but cannot prove cause and effect. Results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma chronic obstructive pulmonary disease chronic rhinosinusitis COPD, severe early onset Crohn disease eosinophilic granulomatosis with polyangiitis rheumatic disorder systemic lupus erythematosus ulcerative colitis vasculitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

  • Rwth Aachen University-Aachen-Germany-C

    Germany, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.